Atypical presentation of giant cell arteritis in a patient with vertebrobasilar stroke: A case report
- PMID: 31393385
- PMCID: PMC6709119
- DOI: 10.1097/MD.0000000000016737
Atypical presentation of giant cell arteritis in a patient with vertebrobasilar stroke: A case report
Erratum in
-
Atypical presentation of giant cell arteritis in a patient with vertebrobasilar stroke: A case report: Erratum.Medicine (Baltimore). 2019 Aug;98(35):e17086. doi: 10.1097/MD.0000000000017086. Medicine (Baltimore). 2019. PMID: 31464970 Free PMC article. No abstract available.
Abstract
Rationale: Giant cell arteritis (GCA) is known to present with typical manifestations like temporal headache and visual abnormalities. However, several cases with atypical manifestations were reported. Stroke occurs in 3% to 7% of patients with GCA.
Patient concerns: A 67-year-old male patient with known hypertension presented with somnolence, disorientation and mild bilateral limb ataxia. The magnetic resonance imaging showed multiple acute infarctions in the territory of the vertebrobasilar system with occlusion of the left vertebral artery.
Diagnosis: Ten months later, during a routine neurovascular follow-up, recanalization of the left vertebral artery was observed and a hypoechoic concentric "halo" sign around both vertebral arteries, mainly on the left side was evident. On further examination of the superficial temporal artery, a hypoechoic concentric "halo" sign was also found, which-along with increased inflammatory markers-raised suspicion about GCA. Classical GCA features like headache, temporal tenderness or amaurosis fugax were not present. Repeated in-depth diagnostic work-up including 48 hours Holter-ECG did not reveal another stroke etiology.
Interventions: Intravenous Methylprednisolone 250 mg/d was immediately started and after 6 days the dose was tapered to 80 mg/d. The patient was discharged on a tapering scheme with the recommendation to start azathioprine. Additionally, we placed the patient on acetylsalicylic acid 100 mg/d and clopidogrel 75 mg/d. However, the patient was not compliant to treatment; he stopped prednisolone early and did not start azathioprine.
Outcomes: The inflammatory markers were markedly reduced at the beginning of the treatment. After stopping the immunosuppressive medications, the inflammatory markers were once again increased. Three months later, the patient developed bilateral middle cerebral artery and right occipital lobe infarctions.
Lessons: In patients with cryptogenic vertebrobasilar strokes, GCA may be considered in the differential diagnosis, especially if the inflammatory markers are increased.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Figures
References
-
- Nuenninghoff DM, Hunder GG, Christianson TJ, et al. Mortality of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum 2003;48:3532–7. - PubMed
-
- Zhang R, Shen J, Jiang W, et al. Giant cell arteritis incidentally detected by positron emission tomography-computed tomography in a patient with atypical symptoms. J Clin Rheumatol 2017;23:115–6. - PubMed
-
- Martins N, Polido-Pereira J, Rodrigues AM, et al. The use of the color Doppler ultrasonography in the diagnosis and monitoring of an atypical case of giant-cell arteritis. Acta Reumatol Port 2016;41:165–6. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
